Bird flu affecting otters and foxes in the UK
After reports of an outbreak of highly pathogenic avian influenza (HPAI) in minks from a farm in Spain, further updates from the UK reveal that the virus has been detected in other mammals. An article by the BBC in February 2023 explained that although this “spill...
CEPI to support 20Med mRNA vaccine technology
In February 2023 CEPI announced a partnership with 20Med, a “leader in non-viral delivery of genetic vaccines” to advance the development of 20Med’s bioresponsive polymeric nanoparticle technology. This is hoped to be a step towards ending the need for frozen storage...
Exclusive interview with Dr Ofer Levy last year
As we continue preparations for the World Vaccine Congress in Washington this April we are delighted to share our final interview from the Congress in Europe
MOST POPULAR THIS MONTH
African leaders vow to end AIDS in children by 2030
At the first ministerial meeting of the Global Alliance to end AIDS in children, leaders from 12 African countries discussed their commitments to ending AIDS in children by 2030. The meeting took place in the United Republic of Tanzania, in Dar es Salaam. A WHO...
IVAC runs vaccine hesitancy training course in India
In December 2022 the International Vaccine Access Centre was able to conduct a test run of its newly developed training course on vaccine hesitancy. With a grant from the Sabin Vaccine Institute the course is aimed at healthcare workers, who can take it online or in...
The 100 days mission: UKHSA assumes responsibility
Of the many lessons that we are endeavouring to learn from the COVID-19 pandemic, the importance of uniting speed with safety is one of the most obvious. With this in mind, in 2021, the world embarked on a joint “mission” to arm ourselves against future threats within...
Cancer vaccines strengthened against aggressive tumours
In research published in Nature biomedical engineering a team of scientists at Northwestern University’s International Institute for Nanotechnology (IIN) explored the effects of structural changes to cancer vaccines. Using chemistry and nanotechnology they changed the...
World Vaccine Congress Washington: meet our start-ups!
Following our previous posts, moving through the start-up zone at the World Vaccine Congress in Washington at speed, we are excited to share a further update: P-N of the start-up zone. If you are interested in joining your colleagues in the start-up area, please make...
Moderna secures FDA Breakthrough Therapy Designation for RSV
Moderna announced in January 2023 that its investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), mRNA-1345, has been granted Breakthrough Therapy Designation by the US FDA. The designation was based on the positive data from the ConquerRSV...
White paper from IAVI: vaccine partnerships for EIDs
In January 2023 IAVI released a white paper after a meeting between global health experts. As a result of a convergence of several diseases in 2022, mpox, ebolavirus, and COVID-19, IAVI and the Rockefeller Foundation established the meeting: “delivering vaccines for...
Marburg vaccine candidate shows in-human promise
A study in The Lancet with NIH funding reported that a vaccine candidate against Marburg virus (MARV) was safe and induced and immune response in a limited, first-in-human trial. Developed by researchers at NIAID, this experimental vaccine “could someday be an...
LATEST
WHO in January 2023: COVID-19 still a PHEIC
The 14th meeting of the International Health Regulations (IHR) Emergency Committee regarding COVID-19 took place on Friday 27th January 2023.
World Neglected Tropical Diseases Day 2023: WHO’s report
On 30th January 2023, WHO released a progress report on neglected tropical diseases (NTD) to coincide with World Neglected Tropical Disease Day
AC Immune Alzheimer’s vaccine shows promise in early trials
Swiss based AC Immune reported in January 2023 that ACI-24.060, its anti-amyloid-beta (Abeta) vaccine, had “elicited an anti-Abeta antibody response”
COVID-19 vaccine strategies: the UK and US plan ahead
Moving into another year of emergence from the COVID-19 pandemic, with vaccines continuing to be a core tool in this process, the UK and US are making moves
Sierra Leone receives CoVDP support worth $2.8 million
In January 2023 Gavi announced a delivery of vehicles and technological goods to the Government of Sierra Leone to support its COVID-19 vaccine deployment.
Conversations with AI: we spoke to ChatGPT about vaccines
As exciting as the rush around ChatGPT is, many of us may be (understandably) concerned about the implications that artificial intelligence has for our futures
VIDEOS
World Vaccine Congress Europe 2022: meet our partners!
At the World Vaccine Congress we are counting down the days to our Congress in Europe, 2022. If you haven't yet bought your tickets there is still time! With under a week to go we are pleased to share a list of supporting partners. You might see some familiar names......
World Vaccine Congress Europe 2022: Chats with Chaudhrey
With just over a week to go until the World Vaccine Congress in Europe 2022, our editor Charlotte was asked to speak to Rizwan Chaudhrey for his YouTube series, #ChatsWithChaudrey. To hear their conversation watch the video below or head to his YouTube channel! If you...
World Vaccine Congress Europe 2022: meet our exhibitors!
We hope you are looking forward to our World Vaccine Congress in Barcelona, 2022; we certainly are! We are pleased to tease some of the amazing exhibitors who will be in attendance in this short video. If you are interested in learning more about exhibiting then...
World Vaccine Congress Europe 2022: meet our sponsors!
Here at the World Vaccine Congress we are looking forward to meeting everyone at our Congress in Barcelona, October 2022. To introduce some the sponsors we have
World Vaccine Congress Europe 2022 trailer!
Check out the trailer for our World Vaccine Congress in Europe 2022!
World Vaccine Congress 2022 Washington reel!
Check out this video from our World Vaccine Congress 2022!
THERAPEUTIC
Cancer vaccines strengthened against aggressive tumours
In research published in Nature biomedical engineering a team of scientists at Northwestern University’s IIN explored the effects of structural changes
AC Immune Alzheimer’s vaccine shows promise in early trials
Swiss based AC Immune reported in January 2023 that ACI-24.060, its anti-amyloid-beta (Abeta) vaccine, had “elicited an anti-Abeta antibody response”
LinKinVax and Gustave Roussy collaborate for human trial
In January 2023 LinKinVax and Gustave Roussy announced a collaboration towards a first-in-human Phase I/IIa clinical trial on a therapeutic vaccine candidate
UK and BioNTech sign MoU for mRNA cancer therapies
In January 2023 BioNTech announced that it had signed a Memorandum of Understanding (MoU) with the UK government to “benefit patients”.
Dual-action vaccine turns cancer on itself
In findings from Brigham and Women’s Hospital published in Science Translational Medicine, researchers reveal newly discovered potential to exploit cancer cells
TECHNOLOGY
Exclusive interview with Dr Ofer Levy last year
As we continue preparations for the World Vaccine Congress in Washington this April we are delighted to share our final interview from the Congress in Europe
CEPI to support 20Med mRNA vaccine technology
In February 2023 CEPI announced a partnership with 20Med to advance the development of 20Med’s bioresponsive polymeric nanoparticle technology.
World Vaccine Congress Washington: meet our start-ups!
Following our previous posts, moving through the start-up zone at the World Vaccine Congress in Washington at speed, we are excited to share a further update
Sierra Leone receives CoVDP support worth $2.8 million
In January 2023 Gavi announced a delivery of vehicles and technological goods to the Government of Sierra Leone to support its COVID-19 vaccine deployment.
Conversations with AI: we spoke to ChatGPT about vaccines
As exciting as the rush around ChatGPT is, many of us may be (understandably) concerned about the implications that artificial intelligence has for our futures
INFECTION
Bird flu affecting otters and foxes in the UK
After reports of an outbreak of HPAI in minks from a farm in Spain, updates from the UK reveal that the virus has been detected in other mammals
African leaders vow to end AIDS in children by 2030
At the first ministerial meeting of the Global Alliance to end AIDS in children, leaders from African countries discussed commitments to ending AIDS in children
Moderna secures FDA Breakthrough Therapy Designation for RSV
Moderna announced in January 2023 that its investigational mRNA vaccine candidate for RSV, mRNA-1345, has been granted Breakthrough Therapy Designation
Marburg vaccine candidate shows in-human promise
A study in The Lancet with NIH funding reported that a vaccine candidate against Marburg virus (MARV) was safe and induced and immune response
WHO in January 2023: COVID-19 still a PHEIC
The 14th meeting of the International Health Regulations (IHR) Emergency Committee regarding COVID-19 took place on Friday 27th January 2023.
GLOBAL HEALTH
IVAC runs vaccine hesitancy training course in India
In December 2022 the International Vaccine Access Centre was able to conduct a test run of its newly developed training course on vaccine hesitancy
The 100 days mission: UKHSA assumes responsibility
Of the many lessons that we are endeavouring to learn from the COVID-19 pandemic, the importance of uniting speed with safety is one of the most obvious.
White paper from IAVI: vaccine partnerships for EIDs
In January 2023 IAVI released a white paper after a meeting between global health experts. As a result of a convergence of several diseases in 2022
World Neglected Tropical Diseases Day 2023: WHO’s report
On 30th January 2023, WHO released a progress report on neglected tropical diseases (NTD) to coincide with World Neglected Tropical Disease Day
WHO launches 2023 funding appeal for $2.54 billion
In January 2023 the WHO launched its 2023 health emergency appeal to support millions of people around the world. The aim is to secure $2.54 billion
